The Nanotechnology in Medical Devices Market size in Latin America is currently valued at USD 795 Million as of 2019 and is forecasted to reach USD 1355 Million by the end of 2024 with a significant CAGR of 11.4% in the review period.
Nanotechnology has great potential to reform the healthcare sector and has witnessed tremendous growth in the previous decade. The growth of the market is expected to sustain in the future owing to the advancements in technology and the increasing incidences of diseases with the aging population. There is increasing optimism that nanotechnology in medicine will bring significant advances in the diagnosis, treatment, and prevention of disease.
Nanotechnology involves the use of nano-robots to repair at the cellular level involving the dimension that are tiny fractions of the human hair. With many nanotechnology-based applications at various stages of testing, it offers exciting opportunities and is believed to revolutionize the treatment for the human body in the future.
The nanotechnology medical device market is driven by a list of factors that include increasing investment by government in nanotechnology, availability of insurance coverage, reimbursement for healthcare expenditure, growing healthcare expenditure and rising aging population. There are also a few restraints the market has to overcome in order to sustain in the future which includes stringent regulatory policies and high cost involving nanotechnology.
This research report segmented and sub-segmented into the following categories:
Top companies in the market
AMAG Pharmaceuticals, Jude Medical, Inc., Smith & Nephew, Inc., PerkinElmer, Inc., Acusphere, Inc., 3M Company, Affymetrix, Inc., Starkey Hearing Technologies are Stryker Corporation are few of the major companies in the Latin America Nanotechnology in Medical Devices Market.
1.1 Market Definition
1.2 Study Deliverables
1.3 Base Currency, Base Year and Forecast Periods
1.4 General Study Assumptions
2.1 Introduction
2.2 Research Phases
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Econometric Modeling
2.2.4 Expert Validation
2.3 Analysis Design
2.4 Study Timeline
3.1 Executive Summary
3.2 Key Inferences
3.3 New Developments
4.1 Market Drivers
4.2 Market Restraints
4.3 Key Challenges
4.4 Current Opportunities in the Market
5.1 By Product
5.1.1 Implantable Material
5.1.1.1 Bone Restorative Material
5.1.1.2 Dental Filling Material
5.1.2active implantable material
5.1.2.1 Hearing Aid Devices
5.1.2.2 Cardio Rhythm Management Devices
5.1.3 Biochips
5.1.4 Medical Textile and Wound Dressing
5.1.5 Others
5.2 By Application
5.2.1 Diagnostics
5.2.2 Therapeutics
5.2.3 Research
6.1 Introduction
6.2 Brazil
6.3 Mexico
6.4 Rest of Latin America
7.1 PESTLE analysis
7.1.1 Political
7.1.2 Economic
7.1.3 Social
7.1.4 Technological
7.1.5 Legal
7.1.6 Environmental
7.2 Porter’s Five analysis
7.2.1 Bargaining Power of Suppliers
7.2.2 Bargaining Power of Consumers
7.2.3 Threat of New Entrants
7.2.4 Threat of Substitute Products and Services
7.2.5 Competitive Rivalry within the Industry
8.1 Acusphere, Inc.
8.1.1 Overview
8.1.2 Product Analysis
8.1.3 Strategic Evaluation and Operations
8.1.4 Financial analysis
8.1.5 Legal issues
8.1.6 Recent Developments
8.1.7 SWOT analysis
8.1.8 Analyst View
8.2 AMAG Pharmaceuticals
8.3 Stryker Corporation
8.4 3M Company
8.5 St. Jude Medical, Inc.
8.6 Affymetrix, Inc.
8.7 Smith & Nephew, Inc.
8.8 PerkinElmer, Inc.
8.9 Starkey Hearing Technologies
9.1 Market share analysis
9.2 Merger and Acquisition Analysis
9.3 Agreements, collaborations and Joint Ventures
9.4 New Product Launches
10.1 Market Outlook
10.2 Investment Opportunities
Appendix
a) List of Tables
b) List of Figures
Related Reports
